Finance

Lists
1801:HKG
Innovent Biologics Inc
HK$96.25
-1.84%
(-1.80) 1D
Oct 2, 4:08:07 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1801...
Open
HK$94.20
High
HK$96.60
Low
HK$92.40
Mkt. cap
167.81B
Avg. vol.
13.16M
Volume
8.90M
P/E ratio
120.26
52-wk high
HK$112.70
52-wk low
HK$69.55
EPS
HK$0.80
No. of employees
9K
Open
HK$94.20
High
HK$96.60
Low
HK$92.40
Mkt. cap
167.81B
Avg. vol.
13.16M
Volume
8.90M
P/E ratio
120.26
52-wk high
HK$112.70
52-wk low
HK$69.55
EPS
HK$0.80
No. of employees
9K
News stories
From web sources and news partners
Profile
Innovent Biologics, Inc. is a publicly listed Chinese biopharmaceutical company that is headquartered in Suzhou, Jiangsu. Wikipedia
About Innovent Biologics Inc
CEOMichael Yu
Employees8.75K
FoundedNov 28, 2011
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.54B
3.54B
4.31B
4.31B
Cost of goods sold
845.12M
845.12M
999.35M
999.35M
Cost of revenue
845.12M
845.12M
999.35M
999.35M
Research and development expenses
807.71M
807.71M
841.85M
841.85M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.91B
1.91B
1.86B
1.86B
Operating expense
2.72B
2.72B
2.71B
2.71B
Total operating expenses
3.56B
3.56B
3.71B
3.71B
Operating income
-19.96M
-19.96M
602.76M
602.76M
Other non operating income
45.19M
45.19M
31.56M
31.56M
EBT including unusual items
-29.10M
-29.10M
805.83M
805.83M
EBT excluding unusual items
-1.59M
-1.59M
738.07M
738.07M
Income tax expense
-18.72M
-18.72M
179.26M
179.26M
Effective tax rate
64.33%
64.33%
22.25%
22.25%
Other operating expenses
-
-
-
-
Net income
-10.38M
-10.38M
626.57M
626.57M
Net profit margin
-0.29%
-0.29%
14.54%
14.54%
Earnings per share
-
-
-
-
Interest and investment income
124.16M
124.16M
178.13M
178.13M
Interest expense
-9.17M
-9.17M
-20.46M
-20.46M
Net interest expenses
114.99M
114.99M
157.67M
157.67M
Depreciation and amortization charges
-
-
-
-
EBITDA
140.29M
140.29M
761.42M
761.42M
Gain or loss from assets sale
-71.00K
-71.00K
1.36M
1.36M
AI content may include mistakes. Learn more
Google apps